Table 4.
Diagnostic Parameters | Kwak- TIRADS |
ACR TI-RADS |
EU- TIRADS |
Korean- TIRADS |
ATA Guidelines |
---|---|---|---|---|---|
Cut-off (benign vs. malignant) |
4c | TR5 | 5 | high | high |
PPV | 0.4 | 0.38 | 0.32 | 0.45 | 0.42 |
(CI-95) | (0.36–0.43) | (0.35–0.42) | (0.30–0.34) | (0.41–0.49) | (0.38–0.46) |
NPV | 0.94 | 0.93 | 0.96 | 0.93 | 0.95 |
(CI-95) | (0.92–0.95) | (0.92–0.94) | (0.94–0.97) | (0.92–0.94) | (0.93–0.96) |
Sensitivity | 0.7 | 0.68 | 0.84 | 0.67 | 0.77 |
(CI-95) | (0.64–0.76) | (0.61–0.74) | (0.78–0.88) | (0.60–0.73) | (0.70–0.83) |
Specificity | 0.8 | 0.8 | 0.67 | 0.85 | 0.8 |
(CI-95) | (0.78–0.82) | (0.77–0.82) | (0.64–0.70) | (0.82–0.87) | (0.77–0.82) |
ACC | 0.79 | 0.78 | 0.7 | 0.82 | 0.79 |
(CI-95) | (0.76–0.81) | (0.75–0.80) | (0.67–0.72) | (0.79–0.84) | (0.77–0.82) |
LHR+ | 3.54 | 3.34 | 2.55 | 4.4 | 3.79 |
(CI-95) | (3.04–4.13) | (2.86–3.91) | (2.29–2.84) | (3.69–5.25) | (3.23–4.42) |
LHR- | 0.37 | 0.41 | 0.25 | 0.39 | 0.29 |
(CI-95) | (0.30–0.46) | (0.33–0.50) | (0.18–0.34) | (0.32–0.48) | (0.22–0.38) |
DOR | 9.58 | 8.26 | 10.4 | 11.37 | 13.08 |
(CI-95) | (6.78–13.57) | (5.88–11.62) | (6.93–15.62) | (8.03–16.11) | (8.87–19.30) |
Abbreviations: RSS—Risk Stratification Systems; PPV—Positive Predictive Value; CI-95—95% Confidence Intervals; NPV—Negative Predictive Value; ACC—Diagnostic Accuracy; LHR+—Positive Likelihood ratio; LHR—Negative Likelihood ratio; DOR—Diagnostic Odds Ratio; TIRADS/TI-RADS—Thyroid Imaging and Reporting Data System; ATA—American Thyroid Association. Thyroid nodules (TNs) that were not classifiable (N/A) are not included.